Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
Clinitech Lab IPO
Clinitech Laboratory Ltd
₹1,15,200 /1200 sharesMinimum investment
IPO details
Minimum investment
₹1,15,200
Price range
₹96 - ₹96
Lot size
1,200
Issue size
5.78 Cr
Face value
10
IPO document
Subscription rate
Data will be available soon
Schedule
25 Jul 2024
IPO open date
29 Jul 2024
IPO close date
30 Jul 2024
Allotment date
30 Jul 2024
Funds unblock or debit
1 Aug 2024
Tentative listing date
About
Founded in
2010
MD/CEO
Mr. Jagdish Umakant Nayak
Parent organisation
Clinitech Laboratory Ltd
Clinitech Lab Financials
Revenue
Total Assets
Profit
All values are in ₹ Cr
Strengths & Risks
Strengths
Risks
The company has received a Certificate of Accreditation from the National Accreditation Board for Testing and Calibration Laboratories (NABL) in line with ISO 15189:2012 standards, recognising the quality of its medical testing facilities.
With three decades of experience, Clinitech Laboratory has fostered enduring relationships with clients, leading to repeat business and opportunities to cross-sell other products and services.
Clinitech Laboratory collaborates with seven doctors who serve as consultants, overseeing the testing processes at its centres. These consultants supervise, analyse, and interpret test results before approving patient reports.
The company's operations are primarily focused in Thane and Navi Mumbai. A loss of business in these areas could significantly harm its overall business performance and financial health.
Clinitech Laboratory relies heavily on a small group of vendors for its supplies. In FY24, FY23, and FY22, purchases from the company’s top 10 vendors accounted for 81.07%, 79.76%, and 92.75% of total purchases, respectively, indicating a high dependency on these suppliers.
The company and its promoter directors are currently involved in legal proceedings. Any unfavourable judgments in these proceedings could lead to significant penalties, which could adversely affect the company's business.
The company has had negative cash flows in the past. Any repeat of this in the future could adversely affect the company’s business.
Application details
For Clinitech Lab IPO, eligible investors can apply as Regular.
| Apply as | Price band | Apply range | Lot size |
|---|---|---|---|
| Regular | ₹96 - ₹96 | ₹2 - ₹5 Lakhs | 1200 |
| High Networth Individual | ₹96 - ₹96 | ₹2 - ₹5 Lakhs | 1200 |